Related references
Note: Only part of the references are listed.Down syndrome and the complexity of genome dosage imbalance
Stylianos E. Antonarakis
NATURE REVIEWS GENETICS (2017)
Introducing Therioepistemology: the study of how knowledge is gained from animal research
Joseph P. Garner et al.
LAB ANIMAL (2017)
Age exacerbates abnormal protein expression in a mouse model of Down syndrome
Md. Mahiuddin Ahmed et al.
NEUROBIOLOGY OF AGING (2017)
Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome
Alexander M. Kleschevnikov et al.
NEUROBIOLOGY OF DISEASE (2017)
Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes
Megan Stringer et al.
PHYSIOLOGY & BEHAVIOR (2017)
Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models
Nicole Creau et al.
BRAIN RESEARCH (2016)
Mouse-based genetic modeling and analysis of Down syndrome
Zhuo Xing et al.
BRITISH MEDICAL BULLETIN (2016)
A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition
Hyeongki Kim et al.
DISEASE MODELS & MECHANISMS (2016)
Mouse models of Down syndrome: gene content and consequences
Meenal Gupta et al.
MAMMALIAN GENOME (2016)
Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model
Irushi Abeysekera et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2016)
SHORT- AND LONG-TERM EFFECTS OF NEONATAL PHARMACOTHERAPY WITH EPIGALLOCATECHIN-3-GALLATE ON HIPPOCAMPAL DEVELOPMENT IN THE Ts65Dn MOUSE MODEL OF DOWN SYNDROME
Fiorenza Stagni et al.
NEUROSCIENCE (2016)
Selective inhibition of the kinase DYRK1A by targeting its folding process
Isao Kii et al.
NATURE COMMUNICATIONS (2016)
DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome
Arnaud Duchon et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2016)
Leucettine L41, a DYRK1A-preferential DYRKs/CLKs inhibitor, prevents memory impairments and neurotoxicity induced by oligomeric Aβ25-35 peptide administration in mice
Gaelle Naert et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2015)
Genetic dissection of the Down syndrome critical region
Xiaoling Jiang et al.
HUMAN MOLECULAR GENETICS (2015)
Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a
Joshua D. Blazek et al.
HUMAN MOLECULAR GENETICS (2015)
Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model
Megan Stringer et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2015)
Pharmacological correction of excitation/inhibition imbalance in Down syndrome mouse models
Benoit Soucher et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Timing of therapies for Down syndrome: the sooner, the better
Fiorenza Stagni et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome
Silvina Catuara-Solarz et al.
Frontiers in Behavioral Neuroscience (2015)
DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome
Sonia Najas et al.
EBIOMEDICINE (2015)
DYRK1A: A Potential Drug Target for Multiple Down Syndrome Neuropathologies
Walter Becker et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Prenatal treatment of Down syndrome: a reality?
Faycal Guedj et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2014)
A patient with partial trisomy 21 and 7q deletion expresses mild Down syndrome phenotype
I. Papoulidis et al.
GENE (2014)
Prefrontal Deficits in a Murine Model Overexpressing the Down Syndrome Candidate Gene Dyrk1a
Aurore Thomazeau et al.
JOURNAL OF NEUROSCIENCE (2014)
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
Rafael De la Torre et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Domains of genome-wide gene expression dysregulation in Down's syndrome
Audrey Letourneau et al.
NATURE (2014)
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage
Benoit Souchet et al.
NEUROBIOLOGY OF DISEASE (2014)
Overexpression of Dyrk1A Is Implicated in Several Cognitive, Electrophysiological and Neuromorphological Alterations Found in a Mouse Model of Down Syndrome
Susana Garcia-Cerro et al.
PLOS ONE (2014)
Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells
Zheng Li et al.
FOOD & FUNCTION (2014)
New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome
Joongkyu Park et al.
Experimental Neurobiology (2014)
cdc-Like/Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases Inhibitor Leucettine L41 Induces mTOR-Dependent Autophagy: Implication for Alzheimer's Disease
Xavier Fant et al.
MOLECULAR PHARMACOLOGY (2014)
Commonality in Down and fetal alcohol syndromes
Jeffrey P. Solzak et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2013)
Long-term running alleviates some behavioral and molecular abnormalities in Down syndrome mouse model Ts65Dn
Elizabeth Kida et al.
EXPERIMENTAL NEUROLOGY (2013)
Protonation of Epigallocatechin-3-gallate (EGCG) Results in Massive Aggregation and Reduced Oral Bioavailability of EGCG-Dispersed Selenium Nanoparticles
Shanshan Wu et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)
Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A
Meritxell Pons-Espinal et al.
NEUROBIOLOGY OF DISEASE (2013)
Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome
Xavier Altafaj et al.
NEUROBIOLOGY OF DISEASE (2013)
Dyrk1A Is Dynamically Expressed on Subsets of Motor Neurons and in the Neuromuscular Junction: Possible Role in Down Syndrome
Gloria Arque et al.
PLOS ONE (2013)
A patient with Down syndrome with a de novo derivative chromosome 21
Zafer Cetin et al.
GENE (2012)
Loss of Correlations among Proteins in Brains of the Ts65Dn Mouse Model of Down Syndrome
Md Mahiuddin Ahmed et al.
JOURNAL OF PROTEOME RESEARCH (2012)
DYRK1A: A master regulatory protein controlling brain growth
Faycal Guedj et al.
NEUROBIOLOGY OF DISEASE (2012)
Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
Noemi Rueda et al.
NEURAL PLASTICITY (2012)
Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
Tatyana Adayev et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes
Mireia Vilardell et al.
BMC GENOMICS (2011)
The use of mouse models to understand and improve cognitive deficits in Down syndrome
Ishita Das et al.
DISEASE MODELS & MECHANISMS (2011)
Green tea polyphenols in drug discovery: a success or failure?
Thomas J. Smith
EXPERT OPINION ON DRUG DISCOVERY (2011)
The role of DYRK1A in neurodegenerative diseases
Jerzy Wegiel et al.
FEBS JOURNAL (2011)
Updated National Birth Prevalence Estimates for Selected Birth Defects in the United States, 2004-2006
Samantha E. Parker et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2010)
Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome
Lina Chakrabarti et al.
NATURE NEUROSCIENCE (2010)
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Yasushi Ogawa et al.
NATURE COMMUNICATIONS (2010)
Complex Contributions of Ets2 to Craniofacial and Thymus Phenotypes of Trisomic Down Syndrome Mice
Cheryl A. Hill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21
Robert Lyle et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Age-dependent dysregulation of brain amyloid precursor protein in the Ts65Dn Down syndrome mouse model
Jennifer H. K. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Faycal Guedj et al.
PLOS ONE (2009)
DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase
Christophe Noll et al.
PLOS ONE (2009)
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies
Jan O. Korbel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down Syndrome
Jon Ortiz-Abalia et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development
Barbara Hammerle et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome
Fei Liu et al.
FASEB JOURNAL (2008)
Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801
A. Siddiqui et al.
GENES BRAIN AND BEHAVIOR (2008)
Gene expression variation increase in trisomy 21 tissues
Ching Yu Chou et al.
MAMMALIAN GENOME (2008)
Gene expression profiling in the adult Down syndrome brain
H. E. Lockstone et al.
GENOMICS (2007)
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent
Kristin R. Landis-Piwowar et al.
CANCER RESEARCH (2007)
Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution
Lei-Chwen Lin et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2007)
Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome
Wieslaw K. Dowjat et al.
NEUROSCIENCE LETTERS (2007)
Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways
Tatyana Adayev et al.
BIOCHEMISTRY (2006)
DYRKIA BAC transgenic mice show altered synaptic plasticity with learning and memory defects
Kyoung-Jin Ahn et al.
NEUROBIOLOGY OF DISEASE (2006)
NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21
Joseph R. Arron et al.
NATURE (2006)
Transcriptional disruptions in Down syndrome: a case study in the Ts1Cje mouse cerebellum during post-natal development
MC Potier et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Understanding the basis for Down syndrome phenotypes
Randall J. Roper et al.
PLOS GENETICS (2006)
Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome
R Lyle et al.
GENOME RESEARCH (2004)
A chromosome 21 critical region does not cause specific down syndrome phenotypes
LE Olson et al.
SCIENCE (2004)
Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain
R Mao et al.
GENOMICS (2003)
Enzymology of methylation of tea catechins and inhibition of catechol-O-methyltransferase by (-)-epigallocatechin gallate
H Lu et al.
DRUG METABOLISM AND DISPOSITION (2003)
Glucuronides of tea catechins: Enzymology of biosynthesis and biological activities
H Lu et al.
DRUG METABOLISM AND DISPOSITION (2003)
The specificities of protein kinase inhibitors: an update
J Bain et al.
BIOCHEMICAL JOURNAL (2003)
Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system
E Martí et al.
BRAIN RESEARCH (2003)
Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice
V Fotaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down's syndrome: a gene expression study
S Bahn et al.
LANCET (2002)
Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome
X Altafaj et al.
HUMAN MOLECULAR GENETICS (2001)
Use of comparative physical and sequence mapping to annotate mouse chromosome 16 and human chromosome 21
MT Pletcher et al.
GENOMICS (2001)
Mice trisomic for a bacterial artificial chromosome with the single-minded 2 gene (Sim2) show phenotypes similar to some of those present in the partial trisomy 16 mouse models of Down syndrome
R Chrast et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
